France's Medixsysteme, developer of therapeutic medical devices for aesthetic, plastic surgery and dermatology markets, has developed the Ultracontour Device. This is the first dual ultrasound instrumentation that uses HIFU and UMD transducers to apply energy below the skin's surface in the subcutaneous tissue for the treatment of fat cells and lymphatic drainage .

Product Highlights
a. This is a non-invasive device.
b. This device treats the subcutaneous fat in the lower part of the body with multiple rays of ultrasonic pulse waves on the superficial tissues.
c. It is a patented device with CE medica l accreditation.
d. It is the first device of its kind to offer both HIFU & UMD technology in one single device.
e. It is highly effective in re-contouring the body.
f. Results are visible within 21 days consisting of 3 sessions.
g. Clinical studies were held over a one year period in Europe and Asia to test the efficacy of this device.

It is currently available in Europe, Asia, South America and the Middle East.